Mediastinal Lymphadenopathy in the National Lung Screening Trial (NLST) Is Associated with Interval Lung Cancer.

Enlarged noncalcified mediastinal lymph nodes in National Lung Screening Trial participants were associated with an increase in lung cancer diagnosis and may warrant more aggressive management.